MODIFICATION
A -- Preclinical Medications Discovery and Abuse Liability Testing for NIDA - Solicitation 1
- Notice Date
- 9/27/2011
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- N01DA-12-8904
- Point of Contact
- Rob Bowman, Phone: (301)443-6677, Kenneth E Goodling, Phone: (301)443-6677
- E-Mail Address
-
bowmanrv@mail.nih.gov, kg25d@nih.gov
(bowmanrv@mail.nih.gov, kg25d@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Request for Proposal (RFP) No. N01DA-12-8904 This contract will acquire services to support the evaluation, in both rodents and primates, of potential pharmacotherapies for drug dependence disorders. It will also provide support for abuse liability-related testing of new street drugs, medications, or potential medications in rodents and primates. The primary emphasis is on testing conducted for NIDA's Addiction Treatment Discovery Program (ATDP). To a lesser extent, the contract will generate abuse liability data for use in decisions pertaining to scheduling of drugs under domestic laws (Controlled Substances Act) and international treaties (Single Convention and Psychotropic Convention). The anticipated deliverables will be written reports detailing study findings.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01DA-12-8904/listing.html)
- Place of Performance
- Address: N/A, United States
- Record
- SN02595020-W 20110929/110928000738-0e3df411562cf54fc5b7a635cb599bb8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |